查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1239485

醫學仿生學市場：按疾病類型（心血管、骨科、眼科、牙科、其他）按應用（傷口癒合、組織工程、藥物輸送等）、全球機會分析和行業預測，2021-2031 年

Medical Biomimetics Market By Disease Type (Cardiovascular, Orthopedic, Ophthalmology, Dental, Others), By Application (Wound Healing, Tissue Engineering, Drug Delivery, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 221 Pages | 商品交期: 2-3個工作天內

價格

預計2021年全球醫療仿生市場規模將達到354億美元，2022-2031年復合年增長率為7.2%，2031年將達到689億美元。

仿生學是一種前沿的設計理念，它利用自然界中存在的方面和過程來解決人類面臨的難題。 “仿生學”一詞來源於兩個古希臘詞“bios”和“mimesis”，分別譯為“生命”和“模仿”。 醫學仿生學是受自然啟發的裝置，用於解決複雜的人類健康問題。 仿生學用於傷口癒合、組織工程、藥物輸送等。 仿生材料可用於治療和保護牙齒、再生心臟、增強自然能力和恢復肢體功能。

推動醫療仿生學市場增長的關鍵因素包括納米膠囊/納米球、納米晶體、脂質體、納米脂質載體/固體脂質納米粒子、納米海綿、用於藥物靶向遞送的基於仿生學的仿生學，包括藥物遞送方面的不斷進步的技術進步，例如作為樹枝狀聚合物的使用。 例如，根據 2022 年 11 月發表的綜述論文《Cell Membrane-Coated Nanoparticles: A Novel Multifunctional Biomimetic Drug Delivery System》，細胞膜表面蛋白的生物學作用歸因於納米粒子的免疫逃逸、循環時間長、靶向這些蛋白質廣泛應用於藥物遞送領域，以賦予遞送等功能。 根據同一消息來源，在仿生方法中，紅細胞膜已被用於包裹聚合物納米顆粒，以減少巨噬細胞的攝取和系統清除。

此外，心髒病的激增正在推動對生物工程技術的需求，以培育人體替代組織，例如 LifeMatrix 組織等下一代植入物，從而推動醫療仿生學市場的增長。 例如，根據美國疾病控制與預防中心 (CDC) 2022 的數據，2020 年美國將有大約 697,000 人死於心髒病。 據同一消息來源稱，美國每年約有 805,000 人心髒病發作。 在這 805,000 人中，有 605,000 人是第一次心髒病發作，200,000 人以前有過心髒病發作。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要影響因素
    • 主要投資機會
  • 波特的五力分析
    • 供應商公司議價能力低
    • 買家的議價能力
    • 替代品威脅較小
    • 新進入者的威脅較小
    • 中等強度的競爭
  • 市場動態
    • 司機
      • 慢性傷口的患病率和發病率上升
      • 牙病患病率上升
      • 心髒病患病率上升
    • 約束因素
      • 嚴格的監管規則和高單位生產成本
    • 機會
      • 加強研發和產品發布
  • 分析 COVID-19 對市場的影響

第 4 章醫療仿生學市場：按疾病類型分類

  • 概覽
    • 市場規模和預測
  • 心血管
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 骨科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 眼科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 牙科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章醫療仿生市場：按應用

  • 概覽
    • 市場規模和預測
  • 傷口癒合
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 人體組織工程
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 給藥
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章醫療仿生學市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機會
    • 按疾病分類的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
  • 歐洲
    • 主要趨勢和機會
    • 按疾病分類的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
  • 亞太地區
    • 主要趨勢和機會
    • 按疾病分類的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機會
    • 按疾病分類的市場規模和預測
    • 市場規模和應用預測
    • 市場規模和預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測
      • 拉丁美洲其他地區/中東/非洲
      • 主要市場趨勢、增長動力和機遇
      • 按疾病分類的市場規模和預測
      • 市場規模和應用預測

第七章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 2021 年主要公司定位

第八章公司簡介

  • Otsuka Medical Devices Co., Ltd.
  • AVINENT Science and Technology
  • CorNeat Vision
  • Swedish Biomimetics 3000 ApS
  • Osteopore International Pte Ltd
  • Curasan, inc.
  • Keystone Dental Group
  • Zimmer Biomet Holding Inc.
  • Biohorizons
  • Blatchford Limited
Product Code: A10865

The global medical biomimetics market size was valued at $35.4 billion in 2021 and is projected to reach $68.9 billion by 2031, growing at a CAGR of 7.2% from 2022 to 2031. Biomimetics is a cutting-edge design idea that uses aspects and processes found in nature to solve challenging human problems. The term "biomimetics" consists of the two ancient Greek words i.e., "bios" and "mimesis," which translate to "life" and "imitate," respectively. Medical biomimetics is a device that draws inspiration from nature to solve complex human problems related to health. Biomimetics is used for wound healing, tissue engineering, and drug delivery. Biomimetic materials can be used to treat and preserve the tooth, cardiac regeneration, enhance natural abilities & restore the function of limbs.

Major factors driving the growth of the medical biomimetics market include a rise in technological advancement in drug delivery, such as the use of nanocapsules/nanospheres, nanocrystals, liposomes, nano lipid carriers/solid lipid nanoparticles, nanosponges and dendrimers based on biomimetics for targeted delivery of the drug. For instance, according to the review article "Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system" published in November 2022, the biological roles of cell membrane surface proteins endow nanoparticles with several functions, such as immune escape, long circulation time, and targeted delivery; therefore, these proteins are being extensively used in the fields of drug delivery. According to the same source, in the biomimetic approach, the erythrocytes membrane is used to coat polymeric nanoparticles in order to reduce macrophage uptake and systemic clearance.

Furthermore, the surge in the prevalence of cardiac diseases propels the demand for bioengineering technology to grow human replacement tissues as next-generation implants such as LifeMatrix tissues drive the growth of the medical biomimetics market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S. died from heart disease in 2020. According to the same source, every year, about 805,000 people in the U.S. have a heart attack. Out of these 805,000 people, 605,000 people have a first heart attack and 200,000 happen to people who have already had a heart attack.

In addition, the rise in the trend of biomimetics products, an increase in awareness regarding biomimetics product, an increase in the number of clinical trials of biomimetics product, rise in the discovery & development of effective medical biomimetics product, drives the growth of the medical biomimetics market. For instance, in July 2020, CorNeat KPro, the first synthetic cornea that bio-integrated with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The CorNeat KPro implant is designed to replace deformed, scarred, or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. The device's lens, which provides optical quality equivalent to a perfect cornea, integrates with resident ocular tissue using a unique and patented synthetic non-degradable nano-fabric skirt placed under the conjunctiva.

However, the high costs of medical biomimetics, health risks, and complications associated with medical biomimetics are expected to hamper the medical biomimetics market growth. On the contrary, unmet medical demands in developing countries and lucrative opportunities in emerging economies are expected to create immense opportunities for medical biomimetics product manufacturers in the future.

Furthermore, the healthcare business is projected to witness growth, owing to a rise in the technological advancements in orthopedic products, a rise in research in the bioengineering field, and the development of advanced medical biomimetics boosting the growth of the medical biomimetics market.

The medical biomimetics market is segmented on the basis of disease type, application, and region. On the basis of disease type, the market is classified into cardiovascular, orthopedic, ophthalmology, dental, and others. On the basis of application, the market is classified into wound healing, tissue engineering, drug delivery, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major players profiled in the report are: AVINENT Science and Technology, BioHorizons, Blatchford Limited, CorNeat Vision, Curasan, Inc., Keystone Dental Group, Osteopore International Pte Ltd, Otsuka Medical Devices group (Veryan Medical Limited), Swedish Biomimetics 3000 ApS, and Zimmer Biomet.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical biomimetics market analysis from 2021 to 2031 to identify the prevailing medical biomimetics market opportunities.
  • Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the medical biomimetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes an analysis of the regional as well as global medical biomimetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Disease Type

  • Ophthalmology
  • Cardiovascular
  • Orthopedic
  • Dental
  • Others

By Application

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • AVINENT Science and Technology
  • CorNeat Vision
  • Osteopore International Pte Ltd
  • Curasan, inc.
  • Biohorizons
  • Otsuka Medical Devices Co., Ltd.
  • Swedish Biomimetics 3000 ApS
  • Keystone Dental Group
  • Blatchford Limited
  • Zimmer Biomet Holding Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. High bargaining power of buyers
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence and incidence of chronic wounds
      • 3.4.1.2. Rise in prevalence of dental disease
      • 3.4.1.3. Rise in prevalence of heart disease
    • 3.4.2. Restraints
      • 3.4.2.1. Strict regulatory rules and high per-unit cost of production
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in R&D and product launch
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Cardiovascular
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Orthopedic
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Ophthalmology
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Dental
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: MEDICAL BIOMIMETICS MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Wound Healing
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Tissue Engineering
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Drug Delivery
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: MEDICAL BIOMIMETICS MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Disease Type
    • 6.2.3. Market size and forecast, by Application
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Disease Type
      • 6.2.4.1.3. Market size and forecast, by Application
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Disease Type
      • 6.2.4.2.3. Market size and forecast, by Application
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Disease Type
      • 6.2.4.3.3. Market size and forecast, by Application
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Disease Type
    • 6.3.3. Market size and forecast, by Application
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Disease Type
      • 6.3.4.1.3. Market size and forecast, by Application
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Disease Type
      • 6.3.4.2.3. Market size and forecast, by Application
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Disease Type
      • 6.3.4.3.3. Market size and forecast, by Application
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Disease Type
      • 6.3.4.4.3. Market size and forecast, by Application
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Disease Type
      • 6.3.4.5.3. Market size and forecast, by Application
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Disease Type
      • 6.3.4.6.3. Market size and forecast, by Application
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Disease Type
    • 6.4.3. Market size and forecast, by Application
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Disease Type
      • 6.4.4.1.3. Market size and forecast, by Application
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Disease Type
      • 6.4.4.2.3. Market size and forecast, by Application
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Disease Type
      • 6.4.4.3.3. Market size and forecast, by Application
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Disease Type
      • 6.4.4.4.3. Market size and forecast, by Application
      • 6.4.4.5. Rest of Asia-Pacific
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Disease Type
      • 6.4.4.5.3. Market size and forecast, by Application
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Disease Type
    • 6.5.3. Market size and forecast, by Application
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Disease Type
      • 6.5.4.1.3. Market size and forecast, by Application
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Disease Type
      • 6.5.4.2.3. Market size and forecast, by Application
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Disease Type
      • 6.5.4.3.3. Market size and forecast, by Application
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Disease Type
      • 6.5.4.4.3. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Otsuka Medical Devices Co., Ltd.
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. AVINENT Science and Technology
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
  • 8.3. CorNeat Vision
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Key strategic moves and developments
  • 8.4. Swedish Biomimetics 3000 ApS
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
  • 8.5. Osteopore International Pte Ltd
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Curasan, inc.
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
  • 8.7. Keystone Dental Group
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Key strategic moves and developments
  • 8.8. Zimmer Biomet Holding Inc.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
  • 8.9. Biohorizons
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
  • 8.10. Blatchford Limited
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. MEDICAL BIOMIMETICS MARKET FOR CARDIOVASCULAR, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. MEDICAL BIOMIMETICS MARKET FOR ORTHOPEDIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. MEDICAL BIOMIMETICS MARKET FOR OPHTHALMOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. MEDICAL BIOMIMETICS MARKET FOR DENTAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. MEDICAL BIOMIMETICS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. GLOBAL MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. MEDICAL BIOMIMETICS MARKET FOR WOUND HEALING, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. MEDICAL BIOMIMETICS MARKET FOR TISSUE ENGINEERING, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. MEDICAL BIOMIMETICS MARKET FOR DRUG DELIVERY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. MEDICAL BIOMIMETICS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. MEDICAL BIOMIMETICS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL BIOMIMETICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. U.S. MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. CANADA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. CANADA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. MEXICO MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. MEXICO MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. EUROPE MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. EUROPE MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. EUROPE MEDICAL BIOMIMETICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. GERMANY MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. GERMANY MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. FRANCE MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. FRANCE MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. UK MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. UK MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. ITALY MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. ITALY MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. SPAIN MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. SPAIN MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. REST OF EUROPE MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. REST OF EUROPE MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. CHINA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. CHINA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. JAPAN MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. JAPAN MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. INDIA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. INDIA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. AUSTRALIA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. AUSTRALIA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. LAMEA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. LAMEA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. LAMEA MEDICAL BIOMIMETICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. BRAZIL MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. BRAZIL MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. SAUDI ARABIA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. SAUDI ARABIA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. SOUTH AFRICA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. SOUTH AFRICA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. REST OF LAMEA MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. REST OF LAMEA MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. OTSUKA MEDICAL DEVICES CO., LTD.: KEY EXECUTIVES
  • TABLE 62. OTSUKA MEDICAL DEVICES CO., LTD.: COMPANY SNAPSHOT
  • TABLE 63. OTSUKA MEDICAL DEVICES CO., LTD.: PRODUCT SEGMENTS
  • TABLE 64. OTSUKA MEDICAL DEVICES CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 65. OTSUKA MEDICAL DEVICES CO., LTD.: KEY STRATERGIES
  • TABLE 66. AVINENT SCIENCE AND TECHNOLOGY: KEY EXECUTIVES
  • TABLE 67. AVINENT SCIENCE AND TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 68. AVINENT SCIENCE AND TECHNOLOGY: PRODUCT SEGMENTS
  • TABLE 69. AVINENT SCIENCE AND TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 70. CORNEAT VISION: KEY EXECUTIVES
  • TABLE 71. CORNEAT VISION: COMPANY SNAPSHOT
  • TABLE 72. CORNEAT VISION: PRODUCT SEGMENTS
  • TABLE 73. CORNEAT VISION: PRODUCT PORTFOLIO
  • TABLE 74. CORNEAT VISION: KEY STRATERGIES
  • TABLE 75. SWEDISH BIOMIMETICS 3000 APS: KEY EXECUTIVES
  • TABLE 76. SWEDISH BIOMIMETICS 3000 APS: COMPANY SNAPSHOT
  • TABLE 77. SWEDISH BIOMIMETICS 3000 APS: PRODUCT SEGMENTS
  • TABLE 78. SWEDISH BIOMIMETICS 3000 APS: PRODUCT PORTFOLIO
  • TABLE 79. OSTEOPORE INTERNATIONAL PTE LTD: KEY EXECUTIVES
  • TABLE 80. OSTEOPORE INTERNATIONAL PTE LTD: COMPANY SNAPSHOT
  • TABLE 81. OSTEOPORE INTERNATIONAL PTE LTD: PRODUCT SEGMENTS
  • TABLE 82. OSTEOPORE INTERNATIONAL PTE LTD: PRODUCT PORTFOLIO
  • TABLE 83. OSTEOPORE INTERNATIONAL PTE LTD: KEY STRATERGIES
  • TABLE 84. CURASAN, INC.: KEY EXECUTIVES
  • TABLE 85. CURASAN, INC.: COMPANY SNAPSHOT
  • TABLE 86. CURASAN, INC.: PRODUCT SEGMENTS
  • TABLE 87. CURASAN, INC.: PRODUCT PORTFOLIO
  • TABLE 88. KEYSTONE DENTAL GROUP: KEY EXECUTIVES
  • TABLE 89. KEYSTONE DENTAL GROUP: COMPANY SNAPSHOT
  • TABLE 90. KEYSTONE DENTAL GROUP: PRODUCT SEGMENTS
  • TABLE 91. KEYSTONE DENTAL GROUP: PRODUCT PORTFOLIO
  • TABLE 92. KEYSTONE DENTAL GROUP: KEY STRATERGIES
  • TABLE 93. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
  • TABLE 94. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
  • TABLE 95. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
  • TABLE 96. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
  • TABLE 97. BIOHORIZONS: KEY EXECUTIVES
  • TABLE 98. BIOHORIZONS: COMPANY SNAPSHOT
  • TABLE 99. BIOHORIZONS: PRODUCT SEGMENTS
  • TABLE 100. BIOHORIZONS: PRODUCT PORTFOLIO
  • TABLE 101. BLATCHFORD LIMITED: KEY EXECUTIVES
  • TABLE 102. BLATCHFORD LIMITED: COMPANY SNAPSHOT
  • TABLE 103. BLATCHFORD LIMITED: PRODUCT SEGMENTS
  • TABLE 104. BLATCHFORD LIMITED: PRODUCT PORTFOLIO
  • TABLE 105. BLATCHFORD LIMITED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. MEDICAL BIOMIMETICS MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL BIOMIMETICS MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL BIOMIMETICS MARKET (2022-2031)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL BIOMIMETICS MARKET
  • FIGURE 10. MEDICAL BIOMIMETICS MARKET, BY DISEASE TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR CARDIOVASCULAR, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR ORTHOPEDIC, BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR DENTAL, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 16. MEDICAL BIOMIMETICS MARKET, BY APPLICATION, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR WOUND HEALING, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR TISSUE ENGINEERING, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR DRUG DELIVERY, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIOMIMETICS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. MEDICAL BIOMIMETICS MARKET BY REGION, 2021
  • FIGURE 22. U.S. MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. CHINA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. JAPAN MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. BRAZIL MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SAUDI ARABIA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SOUTH AFRICA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. REST OF LAMEA MEDICAL BIOMIMETICS MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: MEDICAL BIOMIMETICS MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2021
  • FIGURE 47. OTSUKA MEDICAL DEVICES CO., LTD.: NET REVENUE, 2019-2021 ($BILLION)
  • FIGURE 48. OTSUKA MEDICAL DEVICES CO., LTD.: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($BILLION)
  • FIGURE 49. OTSUKA MEDICAL DEVICES CO., LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 50. OSTEOPORE INTERNATIONAL PTE LTD: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 51. OSTEOPORE INTERNATIONAL PTE LTD: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 52. ZIMMER BIOMET HOLDING INC.: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 53. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2021 (%)